Predicted Trait | |
Reported Trait | Coronary artery disease |
Mapped Trait(s) | coronary artery disease (EFO_0001645) |
Score Construction | |
PGS Name | PRS_EB |
Development Method | |
Name | LD clumping |
Parameters | p=0.39, r^2=0.45 |
Variants | |
Original Genome Build | hg19 |
Number of Variants | 375,822 |
Effect Weight Type | NR |
PGS Source | |
PGS Catalog Publication (PGP) ID | PGP000152 |
Citation (link to publication) | Gola D et al. Circ Genom Precis Med (2020) |
Study Identifiers | Sample Numbers | Sample Ancestry | Cohort(s) |
---|---|---|---|
GWAS Catalog: GCST003116 Europe PMC: 26343387 |
4,095 individuals | Hispanic or Latin American | 41 cohorts
|
GWAS Catalog: GCST003116 Europe PMC: 26343387 |
11,323 individuals | East Asian | 41 cohorts
|
GWAS Catalog: GCST003116 Europe PMC: 26343387 |
25,557 individuals | South Asian | 41 cohorts
|
GWAS Catalog: GCST003116 Europe PMC: 26343387 |
141,217 individuals | European | 41 cohorts
|
GWAS Catalog: GCST003116 Europe PMC: 26343387 |
2,268 individuals | Greater Middle Eastern (Middle Eastern, North African or Persian) | 40 cohorts
|
GWAS Catalog: GCST003116 Europe PMC: 26343387 |
3,139 individuals | African American or Afro-Caribbean | 41 cohorts
|
Study Identifiers | Sample Numbers | Sample Ancestry | Cohort(s) | Phenotype Definitions & Methods | Age of Study Participants | Participant Follow-up Time | Additional Ancestry Description | Additional Sample/Cohort Information |
---|---|---|---|---|---|---|---|---|
— | [
|
European | EB | CAD ascertainment was based on myocardial infarction diagnosis or death cause using ICD-10 codes I21.X, I22.X, I23.X, I24.1, or I25.2 | — | — | — | — |
PGS Performance Metric ID (PPM) |
PGS Sample Set ID (PSS) |
Performance Source | Trait |
PGS Effect Sizes (per SD change) |
Classification Metrics | Other Metrics | Covariates Included in the Model |
PGS Performance: Other Relevant Information |
---|---|---|---|---|---|---|---|---|
PPM001839 | PSS000931| European Ancestry| 431,814 individuals |
PGP000152 | Gola D et al. Circ Genom Precis Med (2020) |
Reported Trait: Coronary artery disease | — | AUROC: 0.6043 [0.6004, 0.6082] | Area under the Precision-Recall curve (AUPRC): 0.0712 [0.0703, 0.076] | — | — |
PPM001837 | PSS000929| European Ancestry| 5,581 individuals |
PGP000152 | Gola D et al. Circ Genom Precis Med (2020) |
Reported Trait: Coronary artery disease | — | AUROC: 0.5407 [0.5253, 0.5561] | Area under the Precision-Recall curve (AUPRC): 0.498 [0.4962, 0.4998] | — | — |
PPM001838 | PSS000930| European Ancestry| 27,048 individuals |
PGP000152 | Gola D et al. Circ Genom Precis Med (2020) |
Reported Trait: Coronary artery disease | — | AUROC: 0.6565 [0.6369, 0.676] | Area under the Precision-Recall curve (AUPRC): 0.0765 [0.0755, 0.0774] | — | — |
PGS Sample Set ID (PSS) |
Phenotype Definitions and Methods | Participant Follow-up Time | Sample Numbers | Age of Study Participants | Sample Ancestry | Additional Ancestry Description | Cohort(s) | Additional Sample/Cohort Information |
---|---|---|---|---|---|---|---|---|
PSS000929 | For GERMIFSI and GERMIFSII, CAD was defined as Myocardinal infarction before the age of 60 and 1 or more 1st- degree relative with CAD. In GERMIFSIII CAD was defined as myocardial infarction between the ages of 26 and 74. In GERMIFSIV, cases were based on a CAD diagnosis before age 65 in men or age 70 in women. In Luric, cases were ascertained as >50% angiographic confirmation of vascular obstruction in 1 or more coronary vessel | — | [
|
— | European | — | GerMIFS, LURIC | — |
PSS000930 | CAD ascertainment was based on myocardial infarction diagnosis or death cause using ICD-10 codes I21.X, I22.X, I23.X, I24.1, or I25.2 | — | [
|
— | European | — | EB | — |
PSS000931 | CAD ascertainment was based on a composite of myocardial infarction or coronary revascularization. Myocardial infarction was based on ICD-9 codes 410.X, 411.X, 412.X, or 429.79, or ICD-10 codes I21.X, I22.X, I23.X, I24.1, or I25.2. Coronary revascularization was assessed based on OPCS-4 coded procedure for coronary artery bypass grafting (K40.1-40-4, K41.1-41.4, or K45.1-45.5), or coronary angioplasty with or without stenting (K49.1-49.2, K49.0-49.9, K50.2, K75.1-75.4, or K75.8-75.9) | — | [
|
— | European | — | UKB | — |